V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010720 | 310005166 | null | 79 | Not known (9) | 2018-03-27 | 2018-03-27 | ICE-R | N | N | 310023294 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310010721 | 310005174 | 1.7 | 42.6 | null | 2017-04-01 | 2017-04-05 | Cisplatin + Fluorouracil + RT 5day | N | N | 310023407 | OXALIPLATIN + MDG |
| 310010722 | 310005180 | 1.69 | 85 | Curative (C) | 2015-09-18 | 2015-09-18 | ECHELON-2 TRIAL | N | N | 310023496 | ATG + BUSULFAN + FLUDARABINE + THIOTEPA |
| 310010723 | 310005182 | 1.6 | 81 | Curative (C) | 2015-06-26 | 2015-06-26 | BCG Intravesical | 2 | N | 310023511 | DHAP |
| 310010724 | 310005185 | null | null | Palliative (P) | 2017-10-19 | 2017-10-27 | BCG Intravesical | N | N | 310023536 | DOXORUBICIN |
| 310010725 | 310005188 | 1.82 | 66.1 | Palliative (P) | 2016-12-06 | 2016-12-24 | DABRAFENIB + TRAMETINIB | Y | N | 310023544 | ABIRATERONE |
| 310010726 | 310005190 | null | 66.3 | Palliative (P) | 2014-03-01 | 2014-03-08 | Gemcitabine + Oxaliplatin | N | N | 310023603 | ICE |
| 310010727 | 310005193 | null | 87.7 | Palliative (P) | 2016-12-10 | 2016-12-10 | R CODOX-M/ R IVAC | 02 | N | 310023631 | IMATINIB |
| 310010729 | 310005199 | null | 87 | Palliative (P) | 2013-12-03 | 2014-08-20 | Cytarabine HD + Methotrexate HD | 2 | N | 310023798 | INTERFERON |
| 310010730 | 310005209 | 1.51 | 82.2 | Neo-adjuvant (N) | 2009-09-26 | 2014-05-14 | Bevacizumab+Carbo+Gemcitabine | N | N | 310023994 | IRINOTECAN + MDG |
| 310010731 | 310005212 | 1.5 | 61.1 | Palliative (P) | 2017-03-13 | 2017-03-14 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 310024014 | ERIBULIN |
| 310010733 | 310005224 | 1.75 | null | Palliative (P) | 2015-08-06 | 2015-08-31 | Thalidomide 100mg | 2 | null | 310024150 | FLUOROURACIL + MITOMYCIN + RT |
| 310010734 | 310008293 | 1.57 | 51.4 | Palliative (P) | 2014-12-07 | 2014-12-20 | Cyclophosphamide Fludarabine (Oral) | null | null | 310024177 | CAPECITABINE |
| 310010735 | 310011744 | 1.55 | 68.9 | null | 2015-06-24 | 2016-02-29 | Cisplatin + Fluorouracil + RT 5day | 2 | N | 310024235 | CISPLATIN + VINORELBINE |
| 310010736 | 310005227 | 1.6 | 61.3 | Palliative (P) | 2018-01-01 | 2018-02-16 | VEDex | 02 | N | 310024239 | CETUXIMAB |
| 310010737 | 310005229 | 0 | 0 | Palliative (P) | 2014-03-04 | 2014-04-23 | CAV | N | N | 310024265 | DACARBAZINE |
| 310010738 | 310009924 | 0.6 | 59.6 | Disease modification (D) | 2015-10-07 | 2016-11-23 | Gemcitabine + Oxaliplatin | N | null | 310024278 | METHOTREXATE |
| 310010739 | 310010805 | 1.5 | 64.5 | Not known (9) | 2013-08-12 | 2013-09-14 | Doxorubicin 75mg/m2 | N | null | 310024290 | OCTOPUS TRIAL |
| 310010740 | 310005234 | 1.82 | 81 | Palliative (P) | 2016-11-08 | 2016-11-09 | CYCLOPHOSPHAMIDE + DOXORUBICIN | N | N | 310024324 | ICE |
| 310010741 | 310011309 | 1.7 | 79.6 | Curative (C) | null | 2014-03-03 | ICE + GCSF | 02 | N | 310024355 | REGORAFENIB |
| 310010742 | 310008300 | 1.64 | 60.2 | Palliative (P) | 2018-07-12 | 2018-07-21 | Dacarbazine | N | N | 310024393 | CAPECITABINE + CISPLATIN + RT |
| 310010743 | 310005238 | 1.67 | 83.3 | null | 2017-06-01 | 2017-06-04 | R-EPOCH | 2 | N | 310024441 | ECX |
| 310010744 | 310005242 | 1.87 | 71 | Neo-adjuvant (N) | 2016-11-07 | 2016-11-08 | BEAM + Alemtuzumab Allo SCT | N | N | 310024459 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310010745 | 310005249 | 1.75 | 65 | Palliative (P) | 2018-02-21 | 2018-02-24 | CISPLATIN + FLUOROURACIL | N | N | 310024541 | ICE |
| 310010747 | 310005259 | 1.54 | 59.75 | Curative (C) | 2017-02-03 | 2017-05-20 | MELPHALAN + TOPOTECAN | N | null | 310024586 | CVP R |
| 310010748 | 310005262 | 1.56 | 90 | Curative (C) | 2018-10-26 | 2018-10-26 | Gemcitabine + Treosulfan (iv) | N | N | 310024633 | IPILIMUMAB + NIVOLUMAB |
| 310010749 | 310011844 | 1.74 | 99 | Curative (C) | 2017-01-26 | 2017-05-16 | Capecitabine | N | N | 310024800 | CISPLATIN + FLUOROURACIL |
| 310010750 | 310005273 | 1.61 | 66.5 | Palliative (P) | 2016-07-02 | 2016-07-12 | ICON8B TRIAL | 2 | N | 310024826 | DOXORUBICIN |
| 310010751 | 310005275 | 0 | null | Palliative (P) | 2018-02-06 | 2018-06-03 | Azacitidine | 02 | N | 310024828 | AZACITIDINE |
| 310010752 | 310005279 | 1.5 | 117 | Disease modification (D) | 2017-07-03 | 2018-05-18 | Imatinib 400mg | N | N | 310024839 | METHOTREXATE |
| 310010753 | 310005283 | null | 67 | Curative (C) | 2014-06-26 | 2016-01-31 | MITOMYCIN | 02 | N | 310024859 | IRINOTECAN + MDG |
| 310010754 | 310008323 | null | 0 | c | 2016-06-04 | 2016-07-17 | Cetuximab + Radiotherapy Maint | null | N | 310024862 | CAV |
| 310010755 | 310005286 | 1.65 | 69.7 | Curative (C) | 2015-03-31 | 2015-03-31 | Trabectedin | N | N | 310024907 | NIVOLUMAB |
| 310010756 | 310010814 | 1.62 | 82 | Curative (C) | 2015-11-23 | 2015-12-02 | IMATINIB | N | N | 310024934 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 310010757 | 310005293 | 1.6 | 62.6 | Adjuvant (A) | 2013-05-13 | 2014-02-08 | Fludarabine + Melphalan RIC Allo | N | null | 310024937 | CAPECITABINE |
| 310010758 | 310011317 | 1.79 | null | Disease modification (D) | 2018-05-06 | 2018-05-11 | IFOSFAMIDE + PACLITAXEL | 02 | N | 310024938 | CYTARABINE |
| 310010759 | 310009947 | 1.72 | 84.7 | Palliative (P) | 2016-08-06 | 2016-08-07 | CVD | 02 | N | 310024973 | GEMCITABINE + OXALIPLATIN |
| 310010761 | 310005306 | 1.84 | 109 | Palliative (P) | 2017-07-27 | 2017-07-28 | Cytarabine HD + Methotrexate HD | N | N | 310025017 | CISPLATIN + ETOPOSIDE |
| 310010762 | 310009948 | 1.62 | null | Curative (C) | 2015-06-21 | 2015-06-28 | PMitCEBO | N | N | 310025049 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310010763 | 310005310 | 1.8 | 60.1 | null | 2018-02-15 | 2018-05-31 | Capecitabine | 2 | N | 310025087 | IRINOTECAN + MDG |
| 310010764 | 310005318 | 1.53 | 82.9 | Palliative (P) | 2018-08-01 | 2018-08-03 | Olaparib | 02 | null | 310025187 | IRINOTECAN + MDG |
| 310010765 | 310005323 | 1.68 | 65.6 | Disease modification (D) | 2017-03-19 | 2017-04-23 | Fludarabine + Melphalan RIC Allo | Y | N | 310025199 | DOXORUBICIN |
| 310010766 | 310005325 | 1.73 | null | Palliative (P) | 2016-05-24 | 2016-12-19 | Doxorubicin 75mg/m2 | N | null | 310025231 | CAPECITABINE + IRINOTECAN |
| 310010767 | 310008344 | null | 101.1 | Curative (C) | 2015-09-28 | 2015-09-28 | LENALIDOMIDE | N | N | 310025231 | CAV |
| 310010768 | 310005327 | 1.52 | null | Palliative (P) | 2014-03-27 | 2014-03-27 | Capecitabine | N | null | 310025291 | TOPOTECAN |
| 310010769 | 310008347 | null | null | Palliative (P) | 2013-12-11 | 2013-12-25 | Cisplatin + Pemetrexed | N | N | 310025333 | METHOTREXATE |
| 310010770 | 310005337 | 1.6 | null | null | 2015-10-22 | 2016-03-11 | Carboplatin + Pemetrexed | 02 | null | 310025341 | EPIRUBICIN |
| 310010771 | 310005343 | 1.7 | 60.6 | Palliative (P) | 2016-05-31 | 2016-09-12 | PERTUZUMAB + TRASTUZUMAB | N | N | 310025360 | CETUXIMAB |
| 310010772 | 310008352 | 1.65 | 60 | Palliative (P) | 2017-11-03 | 2017-11-08 | Chlorambucil | N | N | 310025400 | IVA |
| 310010773 | 310005350 | 1.66 | 59.5 | Curative (C) | 2016-07-26 | 2016-08-05 | Cetuximab 7 day (Cycle 1) | N | N | 310025414 | BEP |